Bicycle Therapeutics Plc (BCYC)
3.45
-0.24
(-6.50%)
USD |
NASDAQ |
Nov 12, 16:00
3.445
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Price : 3.45 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 3.65 | 3.66 | 3.43 | 3.45 | 630102.0 |
| Nov 11, 2026 | 3.73 | 3.75 | 3.66 | 3.69 | 171800.0 |
| Nov 10, 2026 | 3.77 | 3.78 | 3.65 | 3.69 | 234734.0 |
| Nov 09, 2026 | 3.69 | 3.84 | 3.57 | 3.77 | 590289.0 |
| Nov 06, 2026 | 3.50 | 3.685 | 3.49 | 3.61 | 235651.0 |
| Nov 05, 2026 | 3.69 | 3.69 | 3.465 | 3.48 | 499741.0 |
| Nov 04, 2026 | 3.75 | 3.80 | 3.65 | 3.72 | 215100.0 |
| Nov 03, 2026 | 3.61 | 3.71 | 3.61 | 3.67 | 81555.00 |
| Nov 02, 2026 | 3.69 | 3.785 | 3.58 | 3.62 | 348236.0 |
| Oct 30, 2026 | 3.75 | 3.80 | 3.60 | 3.66 | 348588.0 |
| Oct 29, 2026 | 3.92 | 4.135 | 3.705 | 3.82 | 598173.0 |
| Oct 28, 2026 | 3.76 | 3.89 | 3.71 | 3.88 | 436243.0 |
| Oct 27, 2026 | 3.66 | 3.84 | 3.61 | 3.78 | 486230.0 |
| Oct 26, 2026 | 3.56 | 3.69 | 3.53 | 3.65 | 525955.0 |
| Oct 23, 2026 | 3.64 | 3.64 | 3.415 | 3.55 | 346808.0 |
| Oct 22, 2026 | 3.56 | 3.64 | 3.525 | 3.64 | 276237.0 |
| Oct 21, 2026 | 3.62 | 3.797 | 3.56 | 3.57 | 406404.0 |
| Oct 20, 2026 | 3.53 | 3.71 | 3.52 | 3.60 | 488210.0 |
| Oct 19, 2026 | 3.45 | 3.64 | 3.41 | 3.535 | 692063.0 |
| Oct 16, 2026 | 3.58 | 3.60 | 3.42 | 3.46 | 565604.0 |
| Oct 15, 2026 | 3.51 | 3.64 | 3.50 | 3.60 | 411543.0 |
| Oct 14, 2026 | 3.63 | 3.755 | 3.50 | 3.51 | 439358.0 |
| Oct 13, 2026 | 3.81 | 3.88 | 3.63 | 3.63 | 457219.0 |
| Oct 12, 2026 | 3.89 | 3.91 | 3.785 | 3.80 | 233483.0 |
| Oct 09, 2026 | 3.81 | 3.92 | 3.775 | 3.89 | 300616.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Autolus Therapeutics Plc | 1.19 |
| DBV Technologies SA | 11.43 |
| Cellectis SA | 1.33 |
| Akari Therapeutics Plc | 6.51 |
| Biodexa Pharmaceuticals Plc | 2.38 |
Price Related Metrics
| PS Ratio | 2.882 |
| Price to Book Value | 0.4779 |
| Earnings Yield | -58.94% |
| Market Cap | 174.42M |